Form 4: Bausch Health EVP, General Counsel Seana Carson Reports Stock Transactions

Seana Carson, EVP and General Counsel of Bausch Health Companies Inc., reports disposition of shares to cover tax obligations and sales under a pre-arranged Rule 10b5-1 plan.

Summary

• Seana Carson, EVP and General Counsel of Bausch Health Companies Inc., filed a Form 4 detailing changes in beneficial ownership.
• On September 5, 2024, 51,337 common shares were disposed of to satisfy tax withholding obligations at a price of $6.19 per share.
• On September 6, 2024, 13,370 common shares were sold in the open market at a price of $6.21 per share.
• These sales were executed under a Rule 10b5-1 plan adopted on November 6, 2023.
• Following these transactions, Carson directly owns 435,198 common shares.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transactions are routine and pre-planned.

Future Outlook

The reporting person will likely continue to execute sales under the Rule 10b5-1 plan.

Industry Context

Executive stock transactions are common and closely monitored by investors for insights into a company's prospects and management's confidence.

Comparison to Industry Standards

• Executive stock sales are a normal part of compensation and portfolio management.
• Rule 10b5-1 plans are frequently used by executives to avoid insider trading accusations, as they pre-schedule trades.
• Comparable companies such as Teva Pharmaceuticals and Mylan (now Viatris) also see regular Form 4 filings from their executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small volume of shares involved.
• The sales under the 10b5-1 plan are unlikely to significantly affect employee morale or company operations.

Key Dates